References

  1. Ting N. (2006). Introduction and drug development process. In Ting N, ed. Dose Finding in Drug Development. New York: Springer.
  2. Ting N. (2011). Phase 2 clinical development in treating chronic diseases. Drug Information Journal 45: 431–442.
  3. International Conference of Harmonisation. (1997). E8: General Considerations for Clinical Trials. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E8/Step4/E8_Guideline.pdf.
  4. International Conference of Harmonisation. (1994). E4: Dose–Response Information to Support Drug Registration. Available at: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E4/Step4/E4_Guideline.pdf.
  5. Grieve AP. (2011). Adaptive ...

Get Modern Approaches to Clinical Trials Using SAS: Classical, Adaptive, and Bayesian Methods now with the O’Reilly learning platform.

O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.